Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype

被引:638
作者
Sag, Duygu [1 ]
Carling, David [2 ]
Stout, Robert D. [1 ]
Suttles, Jill [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA
[2] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, MRC,Cellular Stress Grp, London, England
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
D O I
10.4049/jimmunol.181.12.8633
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Herein, we demonstrate a role of AMP-activated protein kinase (AMPK) as a potent counterregulator of inflammatory signaling pathways in macrophages. Stimulation of macrophages with anti-inflammatory cytolkines (i.e., IL-10 and TGF beta) resulted in the rapid phosphorylation/activation of AMPK, whereas stimulation of macrophages with a proinflammatory stimulus (LPS) resulted in AMPK dephosphorylation/inactivation. Inhibition of AMPK alpha expression by RNA interference dramatically increased the mRNA levels of LPS-induced TNF-alpha, IL-6, and cyclooxygenase-2. Likewise, expression of a dominant negative AMPK alpha 1 in macrophages enhanced TNF-alpha and IL-6 protein synthesis in response to LPS stimulation, while diminishing the production of IL-10. In contrast, transfection of macrophages with a constitutively active form of AMPK alpha 1 resulted in decreased LPS-induced TNF-alpha and IL-6 production, and heightened production of IL-10. In addition, we found that AMPK negatively regulated LPS-induced I kappa B-alpha degradation and positively regulated Akt activation, accompanied by inhibition or glycogen synthase kinase beta and activation of CREB. Thus, AMPK directs signaling pathways in macrophages in a manner that suppresses proinflammatory responses and promotes macrophage polarization to an anti-inflammatory functional phenotype. The Journal of Immunology, 2008, 181: 8633-8641.
引用
收藏
页码:8633 / 8641
页数:9
相关论文
共 52 条
[21]   The IκB kinase (IKK) and NF-κB:: key elements of proinflammatory signalling [J].
Karin, M ;
Delhase, M .
SEMINARS IN IMMUNOLOGY, 2000, 12 (01) :85-98
[22]   Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase [J].
Kuo, Chih-Lin ;
Ho, Feng-Ming ;
Chang, Mei Ying ;
Prakash, Ekambaranellore ;
Lin, Wan-Wan .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (03) :931-940
[23]   Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway [J].
Manning, BD ;
Tee, AR ;
Logsdon, MN ;
Blenis, J ;
Cantley, LC .
MOLECULAR CELL, 2002, 10 (01) :151-162
[24]   Macrophage polarization comes of age [J].
Mantovani, A ;
Sica, A ;
Locati, M .
IMMUNITY, 2005, 23 (04) :344-346
[25]   Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 [J].
Martin, M ;
Rehani, K ;
Jope, RS ;
Michalek, SM .
NATURE IMMUNOLOGY, 2005, 6 (08) :777-784
[26]   AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle [J].
Merrill, GF ;
Kurth, EJ ;
Hardie, DG ;
Winder, WW .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (06) :E1107-E1112
[27]   M-1/M-2 macrophages and the Th1/Th2 paradigm [J].
Mills, CD ;
Kincaid, K ;
Alt, JM ;
Heilman, MJ ;
Hill, AM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6166-6173
[28]   AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer [J].
Motoshima, Hiroyuki ;
Goldstein, Barry J. ;
Igata, Motoyuki ;
Araki, Eiichi .
JOURNAL OF PHYSIOLOGY-LONDON, 2006, 574 (01) :63-71
[29]   TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages [J].
Mukundan, L ;
Bishop, GA ;
Head, KZ ;
Zhang, LH ;
Wahl, LM ;
Suttles, J .
JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :1081-1090
[30]   5-Aminoimidazole-4-carboxamide ribonucleoside: A novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis [J].
Nath, N ;
Giri, S ;
Prasad, R ;
Salem, ML ;
Singh, AK ;
Singh, I .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :566-574